Investigator:
Katherine A. Siminovitch, MD Location: Mount Sinai Hospital, Toronto, Ontario, Canada
Timeline: March 1, 2004 – ongoing
Dr. Katherine Siminovitch’s study “Identification of Novel Wegener’s granulomatosis Susceptibility Genes” is an ongoing project to collect blood samples from Wegener's patients and their family members.
The goal of the study is to collect blood samples and prepare DNA from 500 patients and their immediate family members, and to conduct a comprehensive clinical chart review in order to obtain powerful data for results stratification and analysis.
The study needs at least 250 more WG patients to donate samples to have sufficient data to develop definitive results. It is very easy to participate in the study. Patients enroll in the study and have a blood sample drawn at their local doctor’s office and shipped to Dr. Siminovitch with the materials provided.
For more information please contact:
Alida Pokoradi, Clinical Research Coordinator
Phone: 416-946-4501 x3297
Fax: 416-946-4531
Email: clinicalgenet.research@gmail.com
To read the complete abstract for the study:
Identification of Novel Wegener’s granulomatosis Susceptibility Genes